{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:59:25Z","timestamp":1776391165712,"version":"3.51.2"},"reference-count":72,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Presentation with advanced glaucoma is the major risk factor for lifetime blindness. Effective intervention at diagnosis is expected to minimise risk of further visual loss in this group of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare clinical and cost-effectiveness of primary medical management compared with primary surgery for people presenting with advanced open-angle glaucoma (OAG).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>Design<\/jats:italic>: A prospective, pragmatic multicentre randomised controlled trial (RCT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Twenty-seven UK hospital eye services.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Four hundred and forty patients presenting with advanced OAG, according to the Hodapp-Parish-Anderson classification of visual field loss.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>Participants will be randomised to medical treatment or augmented trabeculectomy (1:1 allocation minimised by centre and presence of advanced disease in both eyes).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>The primary outcome is vision-related quality of life measured by the National Eye Institute\u2014Visual Function Questionnaire-25 at 24 months. Secondary outcomes include generic EQ-5D-5L, Health Utility Index-3 and glaucoma-related health status (Glaucoma Utility Index), patient experience, visual field measured by mean deviation value, logarithm of the mean angle of resolution visual acuity, intraocular pressure, adverse events, standards for driving and eligibility for blind certification. Incremental cost per quality-adjusted life-year (QALY) based on EQ-5D-5L and glaucoma profile instrument will be estimated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study will report the comparative effectiveness and cost-effectiveness of medical treatment against augmented trabeculectomy in patients presenting with advanced glaucoma in terms of patient-reported health and visual function, clinical outcomes and incremental cost per QALY at 2\u2009years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Treatment of Advanced Glaucoma Study will be the first RCT reporting outcomes from the perspective of those with advanced glaucoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ISRCTN56878850, Pre-results.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-310902","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T16:24:02Z","timestamp":1509035042000},"page":"922-928","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma\u2014study protocol"],"prefix":"10.1136","volume":"102","author":[{"given":"Anthony J","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Fernie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Azuara-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M","family":"Burr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted","family":"Garway-Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemma","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Norrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"2020050713013676000_102.7.922.1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12203"},{"key":"2020050713013676000_102.7.922.2","first-page":"CD004399","article-title":"Medical versus surgical interventions for open angle glaucoma","volume":"9","author":"Burr","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050713013676000_102.7.922.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00873-9"},{"key":"2020050713013676000_102.7.922.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00223-2"},{"key":"2020050713013676000_102.7.922.5","doi-asserted-by":"crossref","first-page":"714-20; discussion 829-30","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"2020050713013676000_102.7.922.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00538-9"},{"key":"2020050713013676000_102.7.922.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62111-5"},{"key":"2020050713013676000_102.7.922.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38506.594977.E0"},{"key":"2020050713013676000_102.7.922.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3518"},{"key":"2020050713013676000_102.7.922.10","unstructured":"National Institute of Health and Care Excellence (NICE). Glaucoma; Diagnosis and management of chronic open angle glaucoma and ocular hypertension CG85. London, UK: NICE, 2009."},{"key":"2020050713013676000_102.7.922.11","unstructured":"American Academy Ophthalmology. Primary Open Angle Glaucoma - Preferred Practise Patterns. Elsevier Inc, 2015."},{"key":"2020050713013676000_102.7.922.12","unstructured":"European Glaucoma Society. Terminology and Guidelines for Glaucoma. 4th\u00a0ed. Italy: Publicomm, 2014."},{"key":"2020050713013676000_102.7.922.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(94)31120-1"},{"key":"2020050713013676000_102.7.922.14","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1989.84"},{"key":"2020050713013676000_102.7.922.15","first-page":"17","article-title":"A comparison between medical and surgical treatment of glaucoma simplex--results of a prospective study","volume":"27","author":"Smith","year":"1968","journal-title":"Trans Ophthalmol Soc Aust"},{"key":"2020050713013676000_102.7.922.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00874-0"},{"key":"2020050713013676000_102.7.922.17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","article-title":"Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis","volume":"123","author":"Li","year":"2016","journal-title":"Ophthalmology"},{"key":"2020050713013676000_102.7.922.18","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.072884"},{"key":"2020050713013676000_102.7.922.19","doi-asserted-by":"publisher","DOI":"10.1159\/000334776"},{"key":"2020050713013676000_102.7.922.20","first-page":"1639","article-title":"Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit","volume":"38","author":"Cordeiro","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713013676000_102.7.922.21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2415-14-41","article-title":"Trabeculectomy with versus without releasable sutures for glaucoma: a meta-analysis of randomized controlled trials","volume":"14","author":"Zhou","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"2020050713013676000_102.7.922.22","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.109835"},{"key":"2020050713013676000_102.7.922.23","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.ophtha.2013.07.049","article-title":"Trabeculectomy in the 21st century: a multicenter analysis","volume":"120","author":"Kirwan","year":"2013","journal-title":"Ophthalmology"},{"key":"2020050713013676000_102.7.922.24","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090523"},{"key":"2020050713013676000_102.7.922.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.12.011"},{"key":"2020050713013676000_102.7.922.26","unstructured":"Hodapp E , Parrish RK , Anderson DR . Clinical decisions in glaucoma. Mosby: St Louis C.V., 1993."},{"key":"2020050713013676000_102.7.922.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(03)80060-1"},{"key":"2020050713013676000_102.7.922.28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(68)91288-9"},{"key":"2020050713013676000_102.7.922.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.03.028"},{"key":"2020050713013676000_102.7.922.30","doi-asserted-by":"publisher","DOI":"10.3109\/09286581003734878"},{"key":"2020050713013676000_102.7.922.31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/IJG.0b013e31824ceb8b","article-title":"Quality of life of medically versus surgically treated glaucoma patients","volume":"22","author":"Guedes","year":"2013","journal-title":"J Glaucoma"},{"key":"2020050713013676000_102.7.922.32","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318265bbf3"},{"key":"2020050713013676000_102.7.922.33","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2020050713013676000_102.7.922.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.08.002"},{"key":"2020050713013676000_102.7.922.35","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0b013e3181339f30"},{"key":"2020050713013676000_102.7.922.36","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150779014"},{"key":"2020050713013676000_102.7.922.37","first-page":"1059","article-title":"Correlation of the binocular visual field with patient assessment of vision","volume":"43","author":"Jampel","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713013676000_102.7.922.38","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200304000-00009"},{"key":"2020050713013676000_102.7.922.39","unstructured":"Health Utilities Inc. Multi-Attribute Health Status Classification System:\u00a0Health Utilities Index Mark 3 (HUI3). http:\/\/www.healthutilities.com\/hui3.htm."},{"key":"2020050713013676000_102.7.922.40","unstructured":"Devlin N , Shah K , Feng Y , et al . Valuing Health-Related Quality of Life: an EQ-5D-5L Value Set for England, Research Paper 16\/01. London: Office of Health Economic,2016."},{"key":"2020050713013676000_102.7.922.41","doi-asserted-by":"publisher","DOI":"10.3310\/hta16150"},{"key":"2020050713013676000_102.7.922.42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-54"},{"key":"2020050713013676000_102.7.922.43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0266462308080288","article-title":"Economic evaluation of screening for open-angle glaucoma","volume":"24","author":"Hern\u00e1ndez","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"key":"2020050713013676000_102.7.922.44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2415-13-72","article-title":"Theoretical and empirical dimensions of the Aberdeen Glaucoma Questionnaire: a cross sectional survey and principal component analysis","volume":"13","author":"Prior","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"2020050713013676000_102.7.922.45","unstructured":"Chehamzeh J . Assessment of glaucoma: Using patient reported measures in randomised controlled trials. University of Aberdeen,2011."},{"key":"2020050713013676000_102.7.922.46","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-3225"},{"key":"2020050713013676000_102.7.922.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.08.051"},{"key":"2020050713013676000_102.7.922.48","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.297"},{"key":"2020050713013676000_102.7.922.49","doi-asserted-by":"publisher","DOI":"10.1007\/BF00184085"},{"key":"2020050713013676000_102.7.922.50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ophtha.2014.08.014","article-title":"Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients","volume":"122","author":"Medeiros","year":"2015","journal-title":"Ophthalmology"},{"key":"2020050713013676000_102.7.922.51","unstructured":"Carpenter J , Kenward M . Missing data in clinical trials \u2014 a practical guide. Birmingham: NIfH, 2008."},{"key":"2020050713013676000_102.7.922.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d40"},{"key":"2020050713013676000_102.7.922.53","doi-asserted-by":"publisher","DOI":"10.1177\/0962280209105014"},{"key":"2020050713013676000_102.7.922.54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1442-9071.2011.02574.x","article-title":"Attitudes of consultant ophthalmologists in the UK to initial management of glaucoma patients presenting with severe visual field loss: a national survey","volume":"39","author":"Stead","year":"2011","journal-title":"Clin Exp Ophthalmol"},{"key":"2020050713013676000_102.7.922.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.08.037"},{"key":"2020050713013676000_102.7.922.56","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32832401a9"},{"key":"2020050713013676000_102.7.922.57","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10618"},{"key":"2020050713013676000_102.7.922.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.037"},{"key":"2020050713013676000_102.7.922.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.03.033"},{"key":"2020050713013676000_102.7.922.60","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2008.523"},{"key":"2020050713013676000_102.7.922.61","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-0886"},{"key":"2020050713013676000_102.7.922.62","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-1609"},{"key":"2020050713013676000_102.7.922.63","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e3181752c83"},{"key":"2020050713013676000_102.7.922.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2010.05.021"},{"key":"2020050713013676000_102.7.922.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.047"},{"key":"2020050713013676000_102.7.922.66","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2014.04.003","article-title":"Visual field improvement in the collaborative initial glaucoma treatment study","volume":"158","author":"Musch","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2020050713013676000_102.7.922.67","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.12.1694"},{"key":"2020050713013676000_102.7.922.68","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302525"},{"key":"2020050713013676000_102.7.922.69","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.eye.6702284","article-title":"Lifetime visual prognosis for patients with primary open-angle glaucoma","volume":"21","author":"Ang","year":"2007","journal-title":"Eye"},{"key":"2020050713013676000_102.7.922.70","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-004-0858-2"},{"key":"2020050713013676000_102.7.922.71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2011.02559.x"},{"key":"2020050713013676000_102.7.922.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.05.027"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-310902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:55:58Z","timestamp":1601110558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-310902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":72,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,6,24]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1136\/bjophthalmol-2017-310902"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310902","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}